Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Infect Dis ; 38(10): 1350-6, 2004 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-15156469

RESUMO

A 37-year-old Belgian patient presented with acute nephropathia epidemica (NE) shortly after a camping holiday in southern France. Unusual symptoms were initial noncardiogenic lung involvement, followed by severe acute renal failure, acute acalculous cholecystitis, presence of immunoblasts in the bone marrow, and hemolytic anemia, presenting as hemolytic uremic syndrome. Positive immunoglobulin (Ig) A and rising IgG titers against Puumala hantavirus (PUUV) were detected, but IgM remained negative on days 8 and 20. The results of reverse-transcriptase-polymerase chain reaction performed on day 8 were positive for PUUV. This is the first report of an iatrogenically IgM-negative hantavirus case due to the selective removal of heavy-weight molecules during plasma exchange via the centrifugation technique. This is also the first report of proven NE from the Mediterranean part of France.


Assuntos
Infecções por Hantavirus/imunologia , Febre Hemorrágica com Síndrome Renal/imunologia , Imunoglobulina M/imunologia , Orthohantavírus , Adulto , Ensaio de Imunoadsorção Enzimática , França , Febre Hemorrágica com Síndrome Renal/virologia , Humanos , Doença Iatrogênica , Masculino
2.
Am J Kidney Dis ; 43(5): e34-8, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15112197

RESUMO

A case of hepatitis C virus (HCV)-negative essential mixed cryoglobulinemia with initial skin, joint, and liver involvement, complicated by severe renal and cardiac failure and resistant to corticosteroid therapy, plasmapheresis, chlorambucil, and cyclophosphamide is presented. Treatment with an anti-CD20 monoclonal antibody (rituximab) induced a persistent recovery of renal and cardiac function, disappearance of skin and joint lesions, and disappearance of cryoglobulins. In a 24-month follow-up period, our patient remains in remission and free of symptoms.


Assuntos
Anticorpos Monoclonais/uso terapêutico , Crioglobulinemia/tratamento farmacológico , Adulto , Anticorpos Monoclonais Murinos , Crioglobulinemia/complicações , Glomerulonefrite Membranoproliferativa/complicações , Insuficiência Cardíaca/etiologia , Humanos , Masculino , Isquemia Miocárdica/complicações , Insuficiência Renal/etiologia , Rituximab
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA